Skip to Content
· Biorevitalisation
SKU 11210

Viscoderm 0.8

In stock
Volume
3 x 1 mL
Laboratory
IBSA
Origin
Italy
Indication
Biorevitalisation, dry and thin skin, fine lines
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Viscoderm 0.8 is an injectable biorevitalisation gel implant by Viscoderm, formulated with native hyaluronic acid at 8 mg/ml whose molecular weight is similar to endogenous hyaluronic acid. It is commonly used by clinics, dermatologists and aesthetic practitioners on especially thin and delicate skin and in preventive biorevitalisation protocols. The hyaluronic acid is obtained by biofermentation from natural raw materials without chemical modification, and the product is intended for professional use by qualified practitioners.

Key Benefits of Viscoderm 0.8

  • Native hyaluronic acid at 8 mg/ml, with a molecular weight similar to endogenous hyaluronic acid
  • Formulated for especially thin and delicate skin areas
  • Suitable for preventive biorevitalisation protocols
  • Hyaluronic acid obtained by biofermentation from natural raw materials, without chemical modification
  • Supports high biocompatibility and good tolerability
  • Improves hydration, skin quality and elasticity
  • Suitable for different professional injection techniques
  • Sterile and apyrogenic syringe content
Key Information
Brand Viscoderm
Manufacturer IBSA
Country of Origin Italy
Certification Classified as a medical product
Ingredients Hyaluronic acid, sodium chloride, sodium phosphate, distilled water
Volume / Size 1 ml per syringe, 3 ml per pack
Packaging 3 syringes x 1 ml, with 6 needles 30G x 12 mm
Needle Size 30G x 12 mm, 6 needles supplied per pack
Use Type Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.

Indications and Professional Use

Main indications

  • Early and moderate age-related skin changes
  • Genetically dry skin prone to fine lines
  • Skin affected by frequent or prolonged sunbed exposure
  • Smoker's skin
  • Stressed skin
  • Skin requiring improved adaptive capacity during acne, pigmentation or aggressive aesthetic treatment courses
  • Post-acne skin rehabilitation
  • Atrophic scars
  • Stretch marks
  • Preventive biorevitalisation procedures
  • Thin and delicate skin areas

Professional use

Viscoderm 0.8 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. The syringe content is sterile and apyrogenic, the product is single-use, and aseptic technique applies throughout; any unused content is discarded. The article notes the product suits different professional injection techniques, and the treating practitioner determines the technique, injection plane, dose per point and session interval for each indication and treated area. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scar formation, blood coagulation disorders, and in patients using anticoagulant or antiplatelet agents.

Treatment areas

  • Face
  • Body
  • Thin and delicate skin areas

Patient profile

Viscoderm 0.8 is intended for adult patients with early or moderate age-related skin changes, dry or stressed skin, or especially thin and delicate skin, and for patients undergoing preventive biorevitalisation. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood coagulation disorders, or in patients taking anticoagulants or antiplatelet agents.

How Viscoderm 0.8 Works

Viscoderm 0.8 works through native hyaluronic acid at 8 mg/ml, obtained by biofermentation from natural raw materials and supplied without chemical modification, so its molecular weight is similar to the hyaluronic acid already present in the skin. Injected intradermally, it restores the dermal hyaluronic acid pool, which improves hydration, skin quality and elasticity. The low concentration in the range makes it suitable for especially thin and delicate skin and for preventive protocols, where a lighter biorevitalising effect is the treatment goal.

Why Order From Allpara

Allpara offers genuine, verified VISCODERM products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.

Which areas can Viscoderm 0.8 be used on?

Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.

Which needles are supplied with Viscoderm 0.8?

Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

/ Specifications

The datasheet

Brand
VISCODERM
Laboratory
IBSA
SKU
11210
Format
3 x 1 mL
Origin
Italy
Indication
Biorevitalisation, dry and thin skin, fine lines
Use
Injectable gel implant, professional use
/ Product details

The full file

Viscoderm 0.8 is an injectable biorevitalisation gel implant by Viscoderm, formulated with native hyaluronic acid at 8 mg/ml whose molecular weight is similar to endogenous hyaluronic acid. It is commonly used by clinics, dermatologists and aesthetic practitioners on especially thin and delicate skin and in preventive biorevitalisation protocols. The hyaluronic acid is obtained by biofermentation from natural raw materials without chemical modification, and the product is intended for professional use by qualified practitioners.

IBSA, country of origin Italy.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.

Which areas can Viscoderm 0.8 be used on?

Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.

Which needles are supplied with Viscoderm 0.8?

Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

/ Quick answers

Everything a buyer asks first

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?
The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.
Which areas can Viscoderm 0.8 be used on?
Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.
Which needles are supplied with Viscoderm 0.8?
Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.
/ FAQ

Frequently asked

The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.
Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.
Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.
No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.
Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

More from IBSA

View laboratory

Clinic alternatives

All products

Viscoderm 0.8

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Viscoderm 0.8 is an injectable biorevitalisation gel implant by Viscoderm, formulated with native hyaluronic acid at 8 mg/ml whose molecular weight is similar to endogenous hyaluronic acid. It is commonly used by clinics, dermatologists and aesthetic practitioners on especially thin and delicate skin and in preventive biorevitalisation protocols. The hyaluronic acid is obtained by biofermentation from natural raw materials without chemical modification, and the product is intended for professional use by qualified practitioners.

Key Benefits of Viscoderm 0.8

  • Native hyaluronic acid at 8 mg/ml, with a molecular weight similar to endogenous hyaluronic acid
  • Formulated for especially thin and delicate skin areas
  • Suitable for preventive biorevitalisation protocols
  • Hyaluronic acid obtained by biofermentation from natural raw materials, without chemical modification
  • Supports high biocompatibility and good tolerability
  • Improves hydration, skin quality and elasticity
  • Suitable for different professional injection techniques
  • Sterile and apyrogenic syringe content
Key Information
Brand Viscoderm
Manufacturer IBSA
Country of Origin Italy
Certification Classified as a medical product
Ingredients Hyaluronic acid, sodium chloride, sodium phosphate, distilled water
Volume / Size 1 ml per syringe, 3 ml per pack
Packaging 3 syringes x 1 ml, with 6 needles 30G x 12 mm
Needle Size 30G x 12 mm, 6 needles supplied per pack
Use Type Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.

Indications and Professional Use

Main indications

  • Early and moderate age-related skin changes
  • Genetically dry skin prone to fine lines
  • Skin affected by frequent or prolonged sunbed exposure
  • Smoker's skin
  • Stressed skin
  • Skin requiring improved adaptive capacity during acne, pigmentation or aggressive aesthetic treatment courses
  • Post-acne skin rehabilitation
  • Atrophic scars
  • Stretch marks
  • Preventive biorevitalisation procedures
  • Thin and delicate skin areas

Professional use

Viscoderm 0.8 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. The syringe content is sterile and apyrogenic, the product is single-use, and aseptic technique applies throughout; any unused content is discarded. The article notes the product suits different professional injection techniques, and the treating practitioner determines the technique, injection plane, dose per point and session interval for each indication and treated area. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scar formation, blood coagulation disorders, and in patients using anticoagulant or antiplatelet agents.

Treatment areas

  • Face
  • Body
  • Thin and delicate skin areas

Patient profile

Viscoderm 0.8 is intended for adult patients with early or moderate age-related skin changes, dry or stressed skin, or especially thin and delicate skin, and for patients undergoing preventive biorevitalisation. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood coagulation disorders, or in patients taking anticoagulants or antiplatelet agents.

How Viscoderm 0.8 Works

Viscoderm 0.8 works through native hyaluronic acid at 8 mg/ml, obtained by biofermentation from natural raw materials and supplied without chemical modification, so its molecular weight is similar to the hyaluronic acid already present in the skin. Injected intradermally, it restores the dermal hyaluronic acid pool, which improves hydration, skin quality and elasticity. The low concentration in the range makes it suitable for especially thin and delicate skin and for preventive protocols, where a lighter biorevitalising effect is the treatment goal.

Why Order From Allpara

Allpara offers genuine, verified VISCODERM products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.

Which areas can Viscoderm 0.8 be used on?

Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.

Which needles are supplied with Viscoderm 0.8?

Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

More from IBSA

View laboratory →

Viscoderm 0.8 is an injectable biorevitalisation gel implant by Viscoderm, formulated with native hyaluronic acid at 8 mg/ml whose molecular weight is similar to endogenous hyaluronic acid. It is commonly used by clinics, dermatologists and aesthetic practitioners on especially thin and delicate skin and in preventive biorevitalisation protocols. The hyaluronic acid is obtained by biofermentation from natural raw materials without chemical modification, and the product is intended for professional use by qualified practitioners.

IBSA, country of origin Italy.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?

The three products differ in hyaluronic acid concentration. Viscoderm 0.8 contains native hyaluronic acid at 8 mg/ml and is the lightest of the range, formulated for especially thin and delicate skin and for preventive protocols. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe and Viscoderm 2.0 contains native hyaluronic acid at 2.0%.

Which areas can Viscoderm 0.8 be used on?

Viscoderm 0.8 is used on the face and body, and is formulated in particular for areas where the skin is especially thin and delicate.

Which needles are supplied with Viscoderm 0.8?

Each Viscoderm 0.8 pack contains 3 syringes of 1 ml and 6 needles of 30G x 12 mm.

Is the hyaluronic acid in Viscoderm 0.8 chemically modified?

No. The hyaluronic acid in Viscoderm 0.8 is obtained by biofermentation from natural raw materials and is produced without chemical modification, which supports its biocompatibility and tolerability.

Who should not be treated with Viscoderm 0.8?

Viscoderm 0.8 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.